Researcher
Stefaan Van Gool
- Disciplines:Paediatrics and neonatology, Nursing
Affiliations
- Inborn Errors of Immunity (Lab)
Member
From1 Jan 2012 → 30 Sep 2016
Projects
1 - 7 of 7
- Local and systemic immune interactions in malignant gliomasFrom1 Aug 2013 → 19 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Computational Horizons in Cancer: Developing Meta- and Hyper-Multiscale Models and Repositories for In Silico Oncology.From1 Apr 2013 → 31 Mar 2017Funding: General Activities (Annex IV)
- Optimalization of immunotherapy in uterine sarcoma.From1 Oct 2012 → 30 Sep 2013Funding: BOF - Other initiatives
- Evaluation of galectin-1 targeting drugs in combination with chemo-immunotherapy in the treatment of high-grade glioma.From1 Aug 2012 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
- Immunotherapy with subcutaneous immunogenic autologous lysate against glioblastomaFrom1 Sep 2011 → 25 Oct 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Comparison of the immunomodulatory capacities of multipotent adult progenitor cells (MAPC) and mesenchymal stem cells (MSC) in graft-versus-host disease (GVHD).From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Lineage plasticity of regulatory T cells in high-grade glioma as a tool to improve immunotherapy.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 97
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma(2013)
Authors: Tina Verschuere, Matthias Van Woensel, Steffen Fieuws, Stefaan Van Gool, Steven De Vleeschouwer
Pages: 9 - 17 - Immunological Response after WT1 mRNA-loaded Dendritic Cell Immunotherapy in Ovarian Carcinoma and Carcinosarcoma(2013)
Authors: An Coosemans, Anke Vanderstraeten, Sandra Tuyaerts, Tina Verschuere, Philippe Moerman, Ignace Vergote, Frédéric Amant, Stefaan Van Gool
Pages: 3855 - 9 - Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?(2013)
Authors: Matthias Van Woensel, Stefaan Van Gool, Steven De Vleeschouwer
Pages: 1020 - 1048 - Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity(2013)
Authors: Tina Verschuere, Jaan Toelen, Wim Maes, Thomas Tousseyn, Holger Gerhardt, Stefaan Van Gool, Steven De Vleeschouwer
Pages: 873 - 884 - Reproducibility of rapid short echo time CSI at 3 tesla for clinical applications(2013)
Authors: Diana Sima, Jan Luts, Annemie Ribbens, Ronald Peeters, Stefan Sunaert, Stefaan Van Gool, Sabine Van Huffel, Uwe Himmelreich
Pages: 445 - 456 - Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years(2013)
Authors: Stefaan Van Gool
Pages: 175 - 184 - Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain(2013)
Authors: Wim Maes, Tina Verschuere, Anaïs Van Hoylandt, Louis Boon, Stefaan Van Gool
Pages: 952469 - Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain(2013)
Authors: Wim Maes, Tina Verschuere, Stefaan Van Gool
- Human Multipotent Adult Progenitor Cells Are Nonimmunogenic and Exert Potent Immunomodulatory Effects on Alloreactive T-Cell Responses(2013)
Authors: Sandra Jacobs, Jef Pinxteren, Catherine Verfaillie, Mark Waer, An Billiau, Stefaan Van Gool
Pages: 1915 - 28 - Foxp3(+) regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade(2013)
Authors: Isabel Vogel Geb.Zinsser, Bert Verbinnen, Wim Maes, Stefaan Van Gool, Jan Ceuppens
Pages: 1013 - 1023